Surgalign Holdings Inc. (NASDAQ:SRGA) shares, rose in value on Wednesday, January 05, with the stock price up by 0.62% to the previous day’s close as strong demand from buyers drove the stock to $0.78.
Actively observing the price movement in the last trading, the stock closed the session at $0.78, falling within a range of $0.7723 and $0.8499. The value of beta (5-year monthly) was 2.10. Referring to stock’s 52-week performance, its high was $3.27, and the low was $0.69. On the whole, SRGA has fluctuated by 6.37% over the past month.
3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
With the market capitalization of Surgalign Holdings Inc. currently standing at about $110.28 million, investors are eagerly awaiting this quarter’s results, scheduled for Mar 14, 2022 – Mar 18, 2022. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.11, which is expected to increase to -$0.1 for fiscal year -$0.42 and then to about -$0.43 by fiscal year 2022. Data indicates that the EPS growth is expected to be 17.60% in 2022, while the next year’s EPS growth is forecast to be -2.40%.
Analysts have estimated the company’s revenue for the quarter at $20.14 million, with a low estimate of $19.3 million and a high estimate of $21.24 million. According to the average forecast, sales growth in current quarter could jump down -23.10%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2022, the company’s y-o-y revenues would reach $88.83 million, representing a decrease of -12.70% from the revenues reported in the last year’s results.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that SRGA’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of SRGA currently trading nearly 3.24% and -6.84% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 50.20, while the 7-day volatility ratio is showing 8.99% which for the 30-day chart, stands at 7.65%. Furthermore, Surgalign Holdings Inc. (SRGA)’s beta value is 2.04, and its average true range (ATR) is 0.06.
Data on historical trading for Surgalign Holdings Inc. (NASDAQ:SRGA) indicates that the trading volumes over the past 10 days have averaged 1.97 million and over the past 3 months, they’ve averaged 2.09 million. According to company’s latest data on outstanding shares, there are 138.32 million shares outstanding.
Nearly 5.40% of Surgalign Holdings Inc.’s shares belong to company insiders and institutional investors own 40.00% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 4.6 million shares as on Dec 14, 2021, resulting in a short ratio of 1.95. According to the data, the short interest in Surgalign Holdings Inc. (SRGA) stood at 3.31% of shares outstanding as of Dec 14, 2021; the number of short shares registered in Nov 14, 2021 reached 3.68 million. The stock has risen by 9.56% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the SRGA stock heading into the next quarter.